期刊文献+

应用非典型抗精神病药物对精神分裂症患者生活质量的影响 被引量:4

Control study of influence of atypical antipsychotics in treating schizophrenics on life quality
原文传递
导出
摘要 目的探讨非典型抗精神病药物长期治疗精神分裂症患者1年后对生活质量的影响。方法选取河南省精神病医院治疗的88例精神分裂症患者,将其随机分成研究组44例和对照组44例,研究组的患者采用非典型抗精神病药物治疗,对照组采用经典抗精神病药物治疗。探讨1年后对患者生活质量的影响。结果研究组患者的生活质量评分(20.64±4.89)分,显著低于对照组患者的生活质量评分,结果具有统计学意义(P<0.05);研究组的个人和社会功能评分(76.69±2.98)分,显著高于对照组的评分,结果具有统计学意义(P<0.05);研究组的不良反应总发生率(36.36%)显著低于对照组,结果具有统计学意义(P<0.05)。结论精神分裂症患者长期采用非典型抗精神病药物进行治疗1年,可使其生活质量显著提高,使患者的个人和社会功能有显著的改善。 Objective To investigate the influence of atypical antipsychotics in treating schizophrenics on life quality af- ter one year. Methods Totally 88 schizophrenics in our hospital were selected and were divided into observation group ( n = 44 ) and control group ( n = 44 ). The observation group was given atypical antipsyehotics and control group was given classic antipsychotics. Results After one year, life quality score of observation group ( 20. 64 _ 4. 89) was obvi- ously lower than that of the control group (28.58 _+ 6. 95 ), the difference was statistically significant (P 〈 0.05 ). Per- sonal and social function score of observation group (76. 69 -+ 2. 98 ) was obviously higher than that of the control group (60. 65 -+ 2. 65 ) , the difference was statistically significant ( P 〈 0. 05 ). Adverse reaction rate of observation group (36. 36% ) was obviously lower than that of the control group (61.36%) , the difference was statistically significant (P 〈 0.05). Conclusions Atypical antipsyehotics in treating schizophrenics in one year can improve the life quality and personal and social function.
出处 《医药论坛杂志》 2015年第11期33-34,37,共3页 Journal of Medical Forum
关键词 抗精神病药物 精神分裂症 生活质量 Antipsychotics Schizophrenics Life quality
  • 相关文献

参考文献7

二级参考文献32

  • 1朱新生,潘理平.抗抑郁药(Antidepressants)的合理应用[J].中华临床医学杂志,2005,6(3):109-111. 被引量:2
  • 2张学立,邱传谦.老年精神病精神药物副作用的观察[J].菏泽医学专科学校学报,1999,11(2):43-44. 被引量:2
  • 3阿依吐逊尼牙孜,于斌.住院精神病人精神药物使用情况调查[J].中国医药导报,2007,4(04X):73-74. 被引量:3
  • 4周春颜.抑郁症及抑郁药物的合理应用[J].辽宁医学杂志,2007,21(3):214-216. 被引量:11
  • 5Melkersson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics (literature review and clinical impli- cations) [J]. Drug, 2004,64(7) : 1-725.
  • 6Lambert BL, Cunningham FE, Miller DR, et al. Diabetes risk associated with use of olanzapine, quetiapine and risperidone in verans health administration patients with schizophrenia[J]. Am J epidemiol, 2006,164(7) :672-681.
  • 7Smith GC, Chaussade C, Vickers M, et al. Atypical antipsycho- tic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat [ J ]. Diabetologia, 2008,51 (12) : 2309-2317.
  • 8Albaugh VL, Henry CR, Bello NT, et al. Hormonal and meta- bolic effects of olanzapine and lozapine related to body weight in rodents[J]. OBESITY, 2006, 14 ( 1 ) : 36-51.
  • 9Kristiana I, Sharpe LJ, Catts VS, et al. Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol [ J ]. Pharmacogeno- mics J, 2010, 10(5) : 396-407.
  • 10Hanssens L, van Winkel R, Wampers M, et al. A cross-sectional evaluation of adiponectin plasma levels in patients with schizophr- enia and schizoaffective disorder [J]. Schizophr Res,2008,106 (2-3) : 308-314.

共引文献33

同被引文献44

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部